A history of Johnson & Johnson
pharmaphorum
FEBRUARY 26, 2021
Beginning in 2003, J&J became involved in a series of litigations with Boston Scientific involving patents covering heart stent medical devices. The litigation was settled in 2009, when Boston Scientific agreed to pay $716 million in September and an additional $1.73 billion the following February.
Let's personalize your content